title: Promising results Halt phase III studies of idelalisib.
authors.forename: Silas
authors.initials: S
authors.lastname: Inman
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D057239:Early Termination of Clinical Trials; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D011687:Purines / Q000627:therapeutic use*; D052999:Quinazolinones / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents; D011687:Purines; D052999:Quinazolinones; C552946:idelalisib